Results 331 to 340 of about 166,918 (340)
Some of the next articles are maybe not open access.
Imaging of Neuroendocrine Tumors
Radiologic Clinics of North America, 2011Neuroendocrine tumors (NETs) constitute a large group of diverse neoplasms with a wide spectrum of clinical, imaging, and pathologic findings. Imaging diagnosis of NETs can be challenging, and several complementary imaging modalities may be needed during the diagnostic workup.
Matthew T, Heller, Amar B, Shah
openaire +2 more sources
Khirurgiya. Zhurnal im. N.I. Pirogova, 2019
Gastrointestinal neuroendocrine tumors are rare neoplasms. Currently, incidence of gastric neuroendocrine tumors (gNETs) is being significantly increased. There are 3 groups of gNETs: types I, II and III. Each type has important features regarding clinical picture, prognosis and treatment strategy. Type I is the most common (70-80%) and associated with
A V, Alekberzade +4 more
openaire +2 more sources
Gastrointestinal neuroendocrine tumors are rare neoplasms. Currently, incidence of gastric neuroendocrine tumors (gNETs) is being significantly increased. There are 3 groups of gNETs: types I, II and III. Each type has important features regarding clinical picture, prognosis and treatment strategy. Type I is the most common (70-80%) and associated with
A V, Alekberzade +4 more
openaire +2 more sources
Management of neuroendocrine tumors
American Journal of Health-System Pharmacy, 2016Current strategies for managing neuroendocrine tumors (NETs) in adult patients are reviewed, with a focus on medication safety concerns.NETs usually originate in the gastrointestinal or bronchopulmonary tract. Symptoms due to hormonal hypersecretion often occur in patients with foregut or midgut NETs or liver metastases.
openaire +2 more sources
Neuroendocrine tumors of the pancreas
Current Gastroenterology Reports, 2009Pancreatic endocrine tumors are rare neoplasms accounting for less than 5% of pancreatic malignancies. They are broadly classified into either functioning tumors (insulinomas, gastrinomas, glucagonomas, VIPomas, and somatostatinomas) or nonfunctioning tumors.
Karen, Davies, Kevin C, Conlon
openaire +2 more sources
[Imaging of neuroendocrine tumors].
La Clinica terapeutica, 2001Neuroendocrine tumors (NET) of the pancreas are distinguished in functional (85%) and non functional (15%) in relation to the production and release of the hormone produced. Functional tumors show early, because the neoplasm release the hormone produced when they are still small. Non functional tumors show late when the tumor grows.
Gualdi GF, Casciani E, Polettini E
openaire +2 more sources
The Genetics of Neuroendocrine Tumors
Seminars in Oncology, 2013Neuroendocrine tumors (NETs) present a wide spectrum of malignant diseases from rather benign to very malignant variants. The majority of these tumors are sporadic, but there are several familial (inherited) syndromes to consider, such as multiple endocrine neoplasia type 1 and type 2 (MEN-1 and MEN-2), von Hippel-Lindau syndrome (VHL), tuberosclerosis,
openaire +2 more sources